
Ozempic Drug Fails to Quell Alzheimer’s in Novo Nordisk Trials
The New York Times - Science •
The studies were a significant setback for the optimistic view that semaglutide and other GLP-1 drugs could help prevent a number of brain diseases.

The New York Times - Science •
The studies were a significant setback for the optimistic view that semaglutide and other GLP-1 drugs could help prevent a number of brain diseases.
The Daily Mail - Science & Technology •
The Independent - Science •

The New York Times - Science •

The Daily Mail - Science & Technology •

The Independent - Science •

New Scientist •

The New York Times - Science •

The Independent - Science •